Far-Infrared Socks for Neuropathic Pain and Nerve Function in Diabetic Patients

Launched by TC ERCIYES UNIVERSITY · Mar 11, 2025

Keywords

ClinConnect Summary

No description provided

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Diagnosed with diabetic peripheral neuropathy (DPN) with mild to moderate severity based on clinical evaluation.
• • Oriented to person, place, and time (cognitively intact).
• • Residing in Kayseri and receiving treatment in the city.
• • HbA1C level below 8.5% during the study period.
• • Non-smoker for at least 6 months.
• • Not using neuropathic pain medication for at least 3 months before enrollment.
• • Body Mass Index (BMI) between 25 - 35.
• • Able to be contacted by phone for follow-up.
• • Willing to participate and provide informed consent.
• Exclusion Criteria:
• • Presence of diabetic foot ulcers.
• • Non-mobilized individuals (unable to walk independently).
• • Severe peripheral artery disease (Ankle Brachial Index (ABI) \< 0.4).
• • Liver failure or renal failure (dialysis patients).
• • Coronary artery disease.
• • Candidates for surgery during the intervention period.
• • Lower extremity arthroplasty or orthosis indication during the intervention period.
• • Neurological or cognitive impairments (e.g., dementia, Alzheimer's disease).
• • Receiving non-pharmacological treatment for diabetic peripheral neuropathy (DPN).
• • Chronic alcohol or substance use.
• • Severe anemia, vitamin B12 deficiency, or iron deficiency anemia.
• • Recent changes in diabetes medication or newly diagnosed with diabetes.
• • Neurological, cardiovascular, or orthopedic damage affecting the lower extremities.
• • Use of cytotoxic or immunosuppressive agents or history of radiation therapy.
• • Pregnant, breastfeeding, or attempting to conceive.
• • Receiving physiotherapy at any point during the study period.